Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2024-10-16 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 78482

Date	Daily Closing Price	Open	High	Low	Volume
16 Wed Oct 2024	2672.35	2715.00	2757.15	2643.05	1.363 times
15 Tue Oct 2024	2703.00	2719.80	2757.50	2681.10	1.66 times
14 Mon Oct 2024	2719.30	2788.85	2812.10	2711.00	1.24 times
11 Fri Oct 2024	2783.45	2764.55	2835.30	2742.10	0.773 times
10 Thu Oct 2024	2761.15	2845.10	2889.90	2755.70	0.775 times
09 Wed Oct 2024	2813.65	2705.15	2884.00	2705.15	1.595 times
08 Tue Oct 2024	2704.70	2639.00	2735.00	2615.00	0.82 times
07 Mon Oct 2024	2613.25	2751.50	2814.50	2586.05	1.528 times
04 Fri Oct 2024	2751.35	2736.20	2769.00	2704.45	0.497 times
03 Thu Oct 2024	2736.20	2713.00	2751.00	2695.00	0.564 times

My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2684.6, but if it comes above 2684.6, then a intra day buy could be more profitable.
If you take a sell trade below 2684.6, then use 2684.6 as stoploss and 2633.5 as target. However if you take a buy trade in stock , then use 2684.6 as stoploss and 2727.19 as target.

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	2235.00
Downside Target	2501.00
Downside Target	2586.05
Downside Target	2643.05
Upside Target	2760.00
Upside Target	2812.10
Upside Target	2825.00
Upside Target	2889.90
Upside Target	2922.80
Upside Target	3088.00

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	2606.23
Downside Intraday Target	2540.12
Upside Intraday Target	2775.28
Upside Intraday Target	2878.22
Upside Intraday Target	2709.17

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
16 Wed Oct 2024	2672.35	2788.85	2812.10	2643.05	0.776 times
11 Fri Oct 2024	2783.45	2751.50	2889.90	2586.05	1.795 times
04 Fri Oct 2024	2751.35	2700.05	2782.25	2695.00	0.877 times
27 Fri Sep 2024	2697.50	2721.00	2765.65	2682.15	0.838 times
20 Fri Sep 2024	2716.60	2921.00	2922.80	2676.25	0.967 times

Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
16 Wed Oct 2024	2672.35	2751.00	2889.90	2586.05	0.595 times
30 Mon Sep 2024	2750.55	2751.85	2922.80	2676.25	0.476 times
30 Fri Aug 2024	2745.10	2740.00	3088.00	2702.10	0.885 times
31 Wed Jul 2024	2730.60	2651.00	2825.00	2501.00	1.134 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term and the sell signal is strong.

Glaxosmithkline Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Glaxosmithkline Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2718.64 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.